Jessica Friedeman Sells 30,000 Shares of LifeMD, Inc. (NASDAQ:LFMD) Stock

LifeMD, Inc. (NASDAQ:LFMD) CMO Jessica Friedeman sold 30,000 shares of the company’s stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $5.66, for a total value of $169,800.00. Following the completion of the transaction, the chief marketing officer now directly owns 170,000 shares in the company, valued at $962,200. The trade was a 15.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

LifeMD Stock Performance

Shares of LFMD stock opened at $5.71 on Tuesday. The stock’s fifty day moving average price is $5.68 and its two-hundred day moving average price is $5.39. The company has a market cap of $254.57 million, a PE ratio of -8.92 and a beta of 1.50. LifeMD, Inc. has a fifty-two week low of $3.99 and a fifty-two week high of $12.88.

LifeMD (NASDAQ:LFMD) last issued its earnings results on Monday, March 10th. The company reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.02. The business had revenue of $64.26 million during the quarter, compared to analyst estimates of $57.43 million. On average, equities analysts predict that LifeMD, Inc. will post -0.56 EPS for the current fiscal year.

Institutional Investors Weigh In On LifeMD

A number of large investors have recently modified their holdings of LFMD. Los Angeles Capital Management LLC boosted its holdings in shares of LifeMD by 852.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 121,585 shares of the company’s stock valued at $637,000 after purchasing an additional 108,822 shares in the last quarter. Royce & Associates LP lifted its stake in shares of LifeMD by 14.6% in the 3rd quarter. Royce & Associates LP now owns 901,041 shares of the company’s stock valued at $4,721,000 after acquiring an additional 114,710 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of LifeMD by 6.7% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 765,916 shares of the company’s stock valued at $4,013,000 after acquiring an additional 48,201 shares during the last quarter. Intech Investment Management LLC bought a new position in shares of LifeMD in the 3rd quarter valued at $54,000. Finally, Integrated Investment Consultants LLC bought a new position in shares of LifeMD in the 3rd quarter valued at $129,000. Institutional investors and hedge funds own 35.52% of the company’s stock.

Analyst Upgrades and Downgrades

LFMD has been the topic of several research reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $15.00 target price on shares of LifeMD in a research report on Tuesday, March 11th. KeyCorp reduced their price target on LifeMD from $10.00 to $7.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 8th. Mizuho initiated coverage on LifeMD in a research report on Wednesday, December 4th. They set a “neutral” rating and a $7.00 price target on the stock. HC Wainwright increased their price target on LifeMD from $12.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday, March 12th. Finally, Lake Street Capital initiated coverage on LifeMD in a research report on Tuesday, December 10th. They set a “buy” rating and a $12.00 price target on the stock. One research analyst has rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $11.43.

About LifeMD

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.